Zurück
HuagongsheHuagongshe Chemie-Druckbericht · Nur für Forschungszwecke
HRID 1658823Erstellt: 23. Oktober 2026

1H-Indazole → Hydrochloric Acid

https://huagongshe.com/de/reaction/1658823

Reaktionsgleichung

Beteiligte Stoffe

RolleNameHCIDEinwaage
Edukt1H-IndazoleHCID 9221—
EduktBenzydamineHCID 12555—
EduktBenzydamine HydrochlorideHCID 65464—
Edukt3-Chloro-N,N-dimethyl-1-propanamineHCID 66960—
EduktSodiumHCID 5360545—
EduktHCID 178518894HCID 178518894—
LösungsmittelO-XyleneHCID 7237—
ProduktHydrochloric AcidHCID 313—
ProduktBenzydamineHCID 12555—

Reaktionsschritte

As described in the aforementioned United States patent specification, indazole compounds embraced by the foregoing general formula II are biologically active in that some manifest analgesic, antiinflammatory and myorelaxing activity. Probably the best known of such compounds at the present time is 1-benzyl-3-[3-(dimethylamino)propoxy]-1H-indazole, commonly referred to as benzydamine, which in the form of the hydrochloride salt, is employed in chemotherapy as an analgesic, antipyretic and/or antiinflammatory agent. In this role, the benzydamine hydrochloride is asssociated in pharmaceutical compositions with pharmaceutically acceptable organic or inorganic, solid or liquid carriers. According to the process described in the aforementioned United States specification, this compound is prepared by heating the sodium salt of 1-benzyl-3-hydroxy-1H-indazole with 3-chloropropyldimethylamine in xylene as an inert solvent. Treatment of the 1benzyl-3-[3-(dimethylamino)propoxy]-1H-indazole so-obtained with ethereal hydrochloric acid yields the corresponding hydrochloride salt, with a melting point of 160°C.

Herkunft & Nachweise

DOI10.6084/m9.figshare.5104873.v1
PatentnummerUS03966761
Quelldatensatzuspto-grants-1976_06
ORD IDord-50f874291df4493cb6cbb0d2eb9897fd
Quellennotizuspto-grants-1976_06